Literature DB >> 27530751

Emergence of endemic MLST non-typeable vancomycin-resistant Enterococcus faecium.

Glen P Carter1,2, Andrew H Buultjens3,2, Susan A Ballard4, Sarah L Baines3,2, Takehiro Tomita4, Janet Strachan4, Paul D R Johnson5, John K Ferguson6, Torsten Seemann3,2,7, Timothy P Stinear3,2, Benjamin P Howden3,2,4.   

Abstract

BACKGROUND: Enterococcus faecium is a major nosocomial pathogen causing significant morbidity and mortality worldwide. Assessment of E. faecium using MLST to understand the spread of this organism is an important component of hospital infection control measures. Recent studies, however, suggest that MLST might be inadequate for E. faecium surveillance.
OBJECTIVES: To use WGS to characterize recently identified vancomycin-resistant E. faecium (VREfm) isolates non-typeable by MLST that appear to be causing a multi-jurisdictional outbreak in Australia.
METHODS: Illumina NextSeq and Pacific Biosciences SMRT sequencing platforms were used to determine the genome sequences of 66 non-typeable E. faecium (NTEfm) isolates. Phylogenetic and bioinformatics analyses were subsequently performed using a number of in silico tools.
RESULTS: Sixty-six E. faecium isolates were identified by WGS from multiple health jurisdictions in Australia that could not be typed by MLST due to a missing pstS allele. SMRT sequencing and complete genome assembly revealed a large chromosomal rearrangement in representative strain DMG1500801, which likely facilitated the deletion of the pstS region. Phylogenomic analysis of this population suggests that deletion of pstS within E. faecium has arisen independently on at least three occasions. Importantly, the majority of these isolates displayed a vancomycin-resistant genotype.
CONCLUSIONS: We have identified NTEfm isolates that appear to be causing a multi-jurisdictional outbreak in Australia. Identification of these isolates has important implications for MLST-based typing activities designed to monitor the spread of VREfm and provides further evidence supporting the use of WGS for hospital surveillance of E. faecium.
© The Author 2016. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2016        PMID: 27530751     DOI: 10.1093/jac/dkw314

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  13 in total

1.  Healthcare-associated infections and antimicrobial resistance in Canadian acute care hospitals, 2014-2018.

Authors:  Canadian Nosocomial Infection Surveillance
Journal:  Can Commun Dis Rep       Date:  2020-05-07

2.  Complete microbial genomes for public health in Australia and the Southwest Pacific.

Authors:  Sarah L Baines; Anders Gonçalves da Silva; Glen P Carter; Amy Jennison; Irani Rathnayake; Rikki M Graham; Vitali Sintchenko; Qinning Wang; Rebecca J Rockett; Verlaine J Timms; Elena Martinez; Susan Ballard; Takehiro Tomita; Nicole Isles; Kristy A Horan; William Pitchers; Timothy P Stinear; Deborah A Williamson; Benjamin P Howden; Torsten Seemann
Journal:  Microb Genom       Date:  2020-11-12

3.  Translating genomics into practice for real-time surveillance and response to carbapenemase-producing Enterobacteriaceae: evidence from a complex multi-institutional KPC outbreak.

Authors:  Jason C Kwong; Courtney R Lane; Finn Romanes; Anders Gonçalves da Silva; Marion Easton; Katie Cronin; Mary Jo Waters; Takehiro Tomita; Kerrie Stevens; Mark B Schultz; Sarah L Baines; Norelle L Sherry; Glen P Carter; Andre Mu; Michelle Sait; Susan A Ballard; Torsten Seemann; Timothy P Stinear; Benjamin P Howden
Journal:  PeerJ       Date:  2018-01-03       Impact factor: 2.984

4.  Evolutionary origins of the emergent ST796 clone of vancomycin resistant Enterococcus faecium.

Authors:  Andrew H Buultjens; Margaret M C Lam; Susan Ballard; Ian R Monk; Andrew A Mahony; Elizabeth A Grabsch; M Lindsay Grayson; Stanley Pang; Geoffrey W Coombs; J Owen Robinson; Torsten Seemann; Paul D R Johnson; Benjamin P Howden; Timothy P Stinear
Journal:  PeerJ       Date:  2017-01-24       Impact factor: 2.984

5.  Emergence of an Australian-like pstS-null vancomycin resistant Enterococcus faecium clone in Scotland.

Authors:  Kimon Lemonidis; Talal S Salih; Stephanie J Dancer; Iain S Hunter; Nicholas P Tucker
Journal:  PLoS One       Date:  2019-06-13       Impact factor: 3.240

6.  Reconstruction of the Genomes of Drug-Resistant Pathogens for Outbreak Investigation through Metagenomic Sequencing.

Authors:  Andre Mu; Jason C Kwong; Timothy P Stinear; Benjamin P Howden; Nicole S Isles; Anders Gonçalves da Silva; Mark B Schultz; Susan A Ballard; Courtney R Lane; Glen P Carter; Deborah A Williamson; Torsten Seemann
Journal:  mSphere       Date:  2019-01-16       Impact factor: 4.389

Review 7.  Genomics of vancomycin-resistant Enterococcus faecium.

Authors:  Claire Gorrie; Charlie Higgs; Glen Carter; Timothy P Stinear; Benjamin Howden
Journal:  Microb Genom       Date:  2019-07-22

8.  Genomic Epidemiology of Vancomycin-Resistant Enterococcus faecium (VREfm) in Latin America: Revisiting The Global VRE Population Structure.

Authors:  Rafael Rios; Jinnethe Reyes; Lina P Carvajal; Sandra Rincon; Diana Panesso; Aura M Echeverri; An Dinh; Sergios-Orestis Kolokotronis; Apurva Narechania; Truc T Tran; Jose M Munita; Barbara E Murray; Paul J Planet; Cesar A Arias; Lorena Diaz
Journal:  Sci Rep       Date:  2020-03-27       Impact factor: 4.379

9.  Emergence of pstS-Null Vancomycin-Resistant Enterococcus faecium Clone ST1478, Canada, 2013-2018.

Authors:  Melissa McCracken; Robyn Mitchell; Stephanie Smith; Susy Hota; John Conly; Tim Du; John Embil; Lynn Johnston; Debbie Ormiston; Jennifer Parsonage; Andrew Simor; Alice Wong; George Golding
Journal:  Emerg Infect Dis       Date:  2020-09       Impact factor: 6.883

10.  Mode and dynamics of vanA-type vancomycin resistance dissemination in Dutch hospitals.

Authors:  Sergio Arredondo-Alonso; Janetta Top; Jukka Corander; Rob J L Willems; Anita C Schürch
Journal:  Genome Med       Date:  2021-01-20       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.